NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $328,585 | +309.6% | 17,096 | +670.4% | 0.02% | +31.6% |
| Q1 2023 | $80,217 | +2573.9% | 2,219 | +3661.0% | 0.02% | +1800.0% |
| Q3 2022 | $3,000 | -97.3% | 59 | -96.2% | 0.00% | -96.2% |
| Q1 2022 | $111,000 | +136.2% | 1,546 | +166.6% | 0.03% | +52.9% |
| Q4 2021 | $47,000 | +2250.0% | 580 | +5700.0% | 0.02% | +1600.0% |
| Q2 2021 | $2,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |